BB Biotech AG/€BION
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About BB Biotech AG
BB Biotech AG is an investment company that focuses on investments in the biotechnology industry. The company is headquartered in Schaffhausen, Switzerland, and specializes in managing a portfolio primarily composed of companies involved in the development of innovative drugs and therapies. It seeks to capture growth opportunities in the biotech sector by investing in firms with cutting-edge scientific research and promising product pipelines. BB Biotech AG's investment strategy is informed by an in-depth analysis of market trends and scientific advancements, ensuring a dynamic and diversified portfolio. Its geographic footprint is primarily in Europe, with strategic investments in biotech firms globally.
Ticker
€BION
Sector
Primary listing
XGAT
Employees
10
Headquarters
Küsnacht, Switzerland
BB Biotech AG Metrics
BasicAdvanced
€1.9B
-
-€8.56
0.79
€1.89
5.34%
Price and volume
Market cap
€1.9B
Beta
0.79
52-week high
€43.27
52-week low
€25.97
Average daily volume
26K
Dividend rate
€1.89
Financial strength
Current ratio
758.286
Quick ratio
0.887
Interest coverage (TTM)
-53.41%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
542.91%
Operating margin (TTM)
134.05%
Effective tax rate (TTM)
-0.01%
Revenue per employee (TTM)
-€8,626,850
Management effectiveness
Return on assets (TTM)
-2.97%
Return on equity (TTM)
-20.74%
Valuation
Price to revenue (TTM)
-22.465
Price to book
0.99
Price to tangible book (TTM)
0.99
Price to free cash flow (TTM)
4.166
Free cash flow yield (TTM)
24.00%
Free cash flow per share (TTM)
8.497
Dividend yield (TTM)
5.34%
Forward dividend yield
5.34%
Growth
Revenue change (TTM)
-141.88%
Earnings per share change (TTM)
-288.16%
3-year revenue growth (CAGR)
-40.30%
10-year revenue growth (CAGR)
-24.80%
3-year earnings per share growth (CAGR)
-29.93%
10-year earnings per share growth (CAGR)
-13.52%
3-year dividend per share growth (CAGR)
-22.39%
10-year dividend per share growth (CAGR)
-2.51%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BB Biotech AG stock?
BB Biotech AG (BION) has a market cap of €1.9B as of September 03, 2025.
What is the P/E ratio for BB Biotech AG stock?
The price to earnings (P/E) ratio for BB Biotech AG (BION) stock is 0 as of September 03, 2025.
Does BB Biotech AG stock pay dividends?
Yes, the BB Biotech AG (BION) stock pays dividends to shareholders. As of September 03, 2025, the dividend rate is €1.88939 and the yield is 5.34%. BB Biotech AG has a payout ratio of 0% on a trailing twelve-month basis.
When is the next BB Biotech AG dividend payment date?
The next BB Biotech AG (BION) dividend payment date is unconfirmed.
What is the beta indicator for BB Biotech AG?
BB Biotech AG (BION) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.